A triple test for screening biological activity of prostacyclin analogues.
6,9-Thiaprostacyclin was used as a representative of prostacyclin analogues with the aim to design the most convenient procedure for evaluation of vasodilator, anti-platelet and other biological properties within this new group of potential anti-thrombotic agents.